In this presentation, the speaker frames chronic inflammation as a fundamental driver of many health problems, describing how it damages receptors, blocks hormone signaling, and keeps the body in a perpetual survival mode. The talk then introduces two anti‑inflammatory peptides. First, GHK‑Copper (GHK‑Cu) is a naturally occurring peptide whose production declines with age; it is highlighted for its ability to modulate the expression of over 4,000 genes, calm inflammatory gene activity, and stimulate collagen synthesis, thereby resetting tissue environments toward a younger, healthier baseline. Second, KPV—a short fragment of the hormone α‑MSH—is presented as a potent inhibitor of the NF‑κB master inflammatory switch. KPV’s primary research focus is gut inflammation, where it can improve nutrient absorption, immune signaling, and even mood by reducing downstream inflammatory cascades. The speaker notes that while KPV is sometimes used for skin inflammation, the evidence is strongest for gastrointestinal applications.
